The MarketWatch News Department was not involved in the creation of this content. Vail, Colorado, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Steadman Philippon Research Institute (SPRI) has secured a $100,000 ...

Vail, Colorado, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Steadman Philippon Research Institute (SPRI) has secured a $100,000 gift from longtime supporter Bjorn Erik Borgen to sustain a critical training and ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Low-code and modular programming environments are transforming PLC programming, with vendors providing pre-packaged libraries and objects that eliminate traditional IEC-61131-3 style coding, allowing ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

The International Olympic Committee is reportedly set to ban transgender women from competing in all female categories. The change is set to be officially announced early next year, The Times reported ...

The esports partnership between the International Olympic Committee (IOC) and Saudi Arabia is no more. On Thursday, the IOC said that it and the Saudi Olympic and Paralympic Committee (SOPC) have ...

GENEVA — The IOC and Saudi Arabia have canceled their 12-year deal to host the video gaming Esports Olympics in Riyadh in a rare setback for a sports project backed by the oil-rich kingdom. The ...

Forbes contributors publish independent expert analyses and insights. Amir is Founder of AI unicorn Avathon & Boeing/SC JV, SkyGrid. Recently, a friend asked me a question that's been floating around ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...